Black Patients Less Likely to Receive Diagnostic Testing in Emergency Department
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 28, 2024 -- Black patients are less likely than White patients with a nonspecific diagnosis of interest to receive related diagnostic testing in the emergency department, according to a study published online Aug. 27 in JAMA Network Open.
Michael I. Ellenbogen, M.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues used a previously validated diagnostic intensity index to assess differences in diagnostic testing rates by race and ethnicity in an acute care setting. The study included emergency department discharges, hospital observation stays, and hospital admissions using administrative claims among emergency departments and acute care hospitals in Kentucky, Maryland, North Carolina, and New Jersey from 2016 through 2018. To estimate rates of nondiagnostic testing, nonspecific principal discharge diagnoses (nausea and vomiting, abdominal pain, chest pain, and syncope) were paired with related diagnostic tests.
Most (80.6 percent) of the 3,683,055 encounters in the study were emergency department discharges. The researchers found that compared with White patients, Black patients discharged from the emergency department with a diagnosis of interest had an adjusted odds ratio of 0.74 for having related diagnostic testing. In none of the acute care settings were other racial or ethnic disparities of a similar magnitude observed.
"White patients discharged from the emergency department had higher rates of nondiagnostic testing, suggesting higher levels of testing overuse. Although Black patients were subjected to less test overuse, this may have come at a risk of undertesting and missed diagnoses," the authors write.
One author disclosed being an inventor on a provisional patent for smartphone-based stroke diagnosis in patients with dizziness, as well as receiving industry grants.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Electrocochleography, MRI Most Reliable for Reclassifying Meniere Disease
FRIDAY, Sept. 6, 2024 -- The most reliable approach to reclassifying patients with probable Meniere disease (MD) includes the combination of electrocochleography (ECochG) and...
GPT-4 With Vision Has Poor Accuracy for Image-Based Radiology Questions
FRIDAY, Sept. 6, 2024 -- The large language model GPT-4 with vision (GPT-4V) has high accuracy for text-only radiology questions, but much lower accuracy for image-based...
Adjunctive IV Argatroban, Eptifibatide Do Not Cut Disability After Stroke
FRIDAY, Sept. 6, 2024 -- Adjunctive treatment with intravenous argatroban or eptifibatide does not reduce poststroke disability among patients with acute ischemic stroke treated...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.